Industries > Pharma > Pharmaceutical Contract Manufacturing Market 2019-2029

Pharmaceutical Contract Manufacturing Market 2019-2029

Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages

PUBLISHED: 19 August 2019
PAGES: 231
PRODUCT CODE: PHA0471
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0471 Categories: , Tags: ,

The pharmaceutical contract manufacturing market is expected to grow at a CAGR of 5.7% in the first half of the forecast period. The API Manufacturing submarket held 67% of the market in 2018. Visiongain estimated that the pharmaceutical contract manufacturing market will reach $138bn in 2024.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 231-page report you will receive 73 tables and 55 figures– all unavailable elsewhere.

The 231-page report provides clear detailed insight into the pharmaceutical contract manufacturing market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global Pharmaceutical Contract Manufacturing Market forecasts from 2019-2029

• Submarket forecasts at world level, from 2019-2029:
• Active pharmaceutical ingredients (APIs), with sub forecasts for generic APIs, high potency active pharma ingredients (HPAPIs) and other products
• Finished dosage formulations (FDFs), with sub forecasts for solid dose forms, injectable dosages and other dosage types
• Other applications of outsourced production – other related services

Pharmaceutical Contract Manufacturing Market 2019-2029

• Revenue forecasts from 2019-2029, for these regional and national markets:
• The US
• Canada
• Japan
• EU5: Germany, France, the UK, Italy and Spain
• BRIC: Brazil, Russia, India, China
• South Korea
• Turkey
• Mexico
• Others

• Assessment of selected leading companies that hold major market shares in the pharmaceutical contract manufacturing industry

• Qualitative Analysis from a CMO Perspective

• Qualitative Analysis from a Client Perspective

• Key questions answered by this report:
• What is the current size of the total global pharmaceutical contract manufacturing market?
• How much will this market be worth from 2018 to 2029?
• How is the pharmaceutical contract manufacturing market evolving?
• What is driving and restraining the pharmaceutical contract manufacturing market?
• What are the market shares of each segment of the overall pharmaceutical contract manufacturing market currently and how will these change to 2029?
• What are the main submarkets and how much revenue will each pharmaceutical contract manufacturing submarket account for over the next 10 years to 2029 and why?
• How will the market shares for each pharmaceutical contract manufacturing submarket develop from 2018 to 2029?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve to 2029?
• What are the largest national markets for pharmaceutical contract manufacturing? What is the current status and how will it develop over the next ten years? What are their forecasts for 2019-2029?
• Who are the most prominent companies, and what are their activities and outlooks?
• What are the main trends that will affect the pharmaceutical contract manufacturing market between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the pharmaceutical contract manufacturing market. You find data, trends and predictions.

Buy our report today Pharmaceutical Contract Manufacturing Market 2019-2029: Active Ingredient (API) and Finished Dose Formulation (FDF), Generic APIs, HPAPIs, Solid Dosages, Injectable Dosages.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharmaceutical Contract Manufacturing Market 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Pharmaceutical Contract Manufacturing Market 2019-2029


Latest Pharma news

A Breakdown of Biosimilar Market Size, Benefits & Challenges

Biosimilars were developed to give consumers more affordable options when it comes to purchasing medicine. In the simplest of terms, they’re a copy of an already existing biological medicine in the marketplace that has been thoroughly tested and deemed safe for use. As the need for more access to healthcare and affordable medicine continues to increase, so has the global …

08 October 2019

READ

“Global Surgical Sutures market set to grow to $6.4bn by 2024” says new Visiongain report

The global market for surgical sutures is witnessing steady growth primarily due to the increasing number of surgical procedures conducted, globally.

08 October 2019

READ

“Gastrointestinal Therapeutics market set to grow to $68bn by 2028” says new Visiongain report

Emerging economies of Asia-Pacific and LAMEA possess high potential for gastrointestinal drugs.

04 October 2019

READ

“Advanced Wound Care market set to grow to $13.8bn by 2024” says Visiongain report

Being the largest and fastest growing segment of the wound care market, the Advanced wound care market will witness healthy growth during the forecast period.

03 October 2019

READ

Categories

Category